Le Lézard
Classified in: Health, Business
Subject: LIC

Independence Blue Cross signs on to White House Healthcare AI Commitments


PHILADELPHIA, Feb. 28, 2024 /PRNewswire/ -- Today, Independence Blue Cross (IBX) announced it has signed on to the White House Healthcare AI Commitments. IBX joins 36 forward-thinking insurers and healthcare provider peers to collaborate with the White House and determine how to leverage frontier AI models that drive change in healthcare.

"Independence Blue Cross continues to lead the way in healthcare innovation. We are dedicated to advocating for advancements that improve care delivery, user experience, and affordability," said Mike Vennera, executive vice president and chief strategy, development, and information officer for Independence Blue Cross. "We're proud to have a seat at the table, among other policy experts and national thought leaders. Together, we will procure, develop, and leverage large-scale machine learning models that can perform a variety of tasks. What's more, we are committed to pursuing these once in a generation innovations and benefits while mitigating risks and protecting patient information."

The agreement signed by IBX underscores three fundamental principles to the future of AI: safety, security, and trust. Signatories agreed to five main components:

  1. To commit to vigorously developing AI solutions to optimize healthcare delivery and payment by advancing health equity, expanding access, making healthcare more affordable, improving outcomes through more coordinated care, improving patient experience, and reducing clinician burnout.

  2. To work with our peers and partners to ensure outcomes are aligned with fair, appropriate, valid, effective, and safe (FAVES) AI principles.

  3. To deploy trust mechanisms that inform users if content is largely AI-generated and not reviewed or edited by a human.

  4. To adhere to a risk management framework that includes comprehensive tracking of applications powered by frontier models and an accounting for potential harms and steps to mitigate them.

  5. To research, investigate, and develop swiftly, but do so responsibly.

IBX and the 36 other signatories will revisit and revise commitments at reasonable intervals as more is learned from frontier models. More information on the commitments can be found at www.healthcareaicommitments.com.

About Independence Blue Cross
Independence Blue Cross is the leading health insurance organization in southeastern Pennsylvania. For 85 years, we have been enhancing the health and well-being of the people and communities we serve. We deliver innovative and competitively priced health care products and services; pioneer new ways to reward doctors, hospitals, and other health care professionals for coordinated, quality care; and support programs and events that promote wellness. To learn more, visit ibx.com. Connect with us on Facebook, X (formerly Twitter), LinkedIn, and Instagram. Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association.

CONTACT:

Diana Quattrone


215-815-7828


[email protected]

SOURCE Independence Blue Cross


These press releases may also interest you

at 06:00
Fennec Pharmaceuticals Inc. , a commercial stage specialty pharmaceutical company, today announced that Adrian Haigh has departed from his position as Fennec's Chief Operating Officer as of June 30, 2024. After nine years as an independent director,...

at 06:00
Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") , a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries in China, announced today that its board of directors...

at 06:00
BrainStorm Cell Therapeutics Inc. , a leading developer of adult stem cell therapeutics for neurodegenerative diseases, announced today that it will hold a mid-year corporate update to discuss recent positive developments in the NurOwn® program on...

at 05:26
Pope Francis hosted distinguished scientists and experts from various countries and disciplines at a private audience at the Apostolic Palace in Vatican City. The selected attendees were participants in the Three-day International Conference on...

at 05:05
LimmaTech Biologics AG, a clinical-stage biotech company developing vaccines for the prevention of life-threatening diseases, today announced the appointment of Staph Leavenworth Bakali as independent Chairman of its Board of Directors. Mr....

at 04:30
1 in 2 adults in the US have high blood pressure, and if you're over 55, the odds jump to 4 in 5. Given that heart attacks are the No.1 killer of men and women around the world, often precipitated by high blood...



News published on and distributed by: